A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction

By H. Isayama, Y. Komatsu, T. Tsujino, N. Sasahira, K. Hirano, N. Toda, Y. Nakai, N. Yamamoto, M. Tada, Hideo Yoshida and 3 more. Gut, 2004

628 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline – Updated October 2017 (2018, background): “Of note, measures taken in some studies to prevent this complication have included placement of the stent covering below the level of the cystic duct implantation in patients with an intact gallbladder [64] and the use of covered SEMS with transmural drainage holes [65].”
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update (2012, positive): “Patency was higher in pancreatic cancer and in lymphadenopathy-associated obstruction compared with biliary malignancy, but numbers of the latter were small.(103) Another RCT demonstrated improved survival in patients with extrahepatic CC who percutaneously received a covered (243 days) compared wit”